A Single-arm, Prospective, Single-center, Phase II Clinical Study of Penpulimab Combined With RMA in the Treatment of Newly Diagnosed Primary CNS Lymphoma
Latest Information Update: 10 Jan 2023
At a glance
- Drugs Cytarabine (Primary) ; Methotrexate (Primary) ; Penpulimab (Primary) ; Rituximab (Primary)
- Indications CNS cancer; Diffuse large B cell lymphoma
- Focus Therapeutic Use
Most Recent Events
- 13 Dec 2022 Preliminary results (n=11) presented at the 64th American Society of Hematology Annual Meeting and Exposition
- 29 Apr 2022 New trial record